Your browser doesn't support javascript.
loading
Twenty-Four Hour Blood Pressure Response to Empagliflozin and Its Determinants in Normotensive Non-diabetic Subjects.
Zanchi, Anne; Pruijm, Menno; Muller, Marie-Eve; Ghajarzadeh-Wurzner, Arlène; Maillard, Marc; Dufour, Nathalie; Bonny, Olivier; Wuerzner, Grégoire; Burnier, Michel.
Afiliación
  • Zanchi A; Service of Nephrology and Hypertension, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Pruijm M; Service of Endocrinology, Diabetes and Metabolism, Lausanne University Hospital, Lausanne, Switzerland.
  • Muller ME; Service of Nephrology and Hypertension, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Ghajarzadeh-Wurzner A; Service of Nephrology and Hypertension, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Maillard M; Service of Nephrology and Hypertension, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Dufour N; Service of Nephrology and Hypertension, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Bonny O; Service of Nephrology and Hypertension, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Wuerzner G; Service of Nephrology and Hypertension, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
  • Burnier M; Service of Nephrology and Hypertension, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Front Cardiovasc Med ; 9: 854230, 2022.
Article en En | MEDLINE | ID: mdl-35391843

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Front Cardiovasc Med Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Prognostic_studies Idioma: En Revista: Front Cardiovasc Med Año: 2022 Tipo del documento: Article